Title:
【発明の名称】炎症性疾患の治療のための非経口的に投与される医薬を調製するためのエマルジョンの使用
Document Type and Number:
Japanese Patent JPH08500332
Kind Code:
A
Abstract:
The object of the invention is the use of an emulsion containing one or more polyunsaturated, long-chained omega-3 fatty acids or their pharmaceutically acceptable esters or salts and the usual adjuvants or additives to produce a medicament to be parenterally administered for the treatment of inflammatory diseases, especially inflammatory lung diseases, inflammatory intestinal diseases and lupus erythematodes, especially mucoviscidosis and/or colitis ulcerosa. In the emulsions used in the invention, the omega-3 fatty acids, their pharmaceutically acceptable esters or salts are contained in pure form or as a component of oils like natural, prepared, semi-synthetic or synthetic oils, preferably fish oils. The preferred forms of such emulsions are those containing oils, preferably fish oils, glycerin, at least one emulsifier and water for injection purposes, in which the oils contain at least 20 wt % omega-3 fatty acids.
Inventors:
Ascanage, Jeffrey
Kates, David Pee
Schlotzer, Ewald
Furst, Peter
Kates, David Pee
Schlotzer, Ewald
Furst, Peter
Application Number:
JP51890693A
Publication Date:
January 16, 1996
Filing Date:
April 27, 1993
Export Citation:
Assignee:
Fresenius Age
International Classes:
A61K31/20; A61K31/23; A61K35/60; A61K47/10; A61K47/24; A61P29/00; A61K9/107; (IPC1-7): A61K31/20; A61K9/107; A61K31/23; A61K35/60; A61K47/10; A61K47/24
Attorney, Agent or Firm:
Takehiko Suzue (3 outside)
Previous Patent: タキキニンアンタゴニスト三環式化合物、その製造法並びにそれを含む医...
Next Patent: 新規なＧＡＢＡａレセプタサブタイプ，並びにＧＡＢＡａレセプタサブタ...
Next Patent: 新規なＧＡＢＡａレセプタサブタイプ，並びにＧＡＢＡａレセプタサブタ...